Kantum Pharma
PrivateLast Round
Series A
Jul 12, 2021
Total Funding Raised
$6.73M
Company Overview
Kantum Pharma operates in Healthcare & Life Sciences and is based in Concord, New Hampshire. Its latest recorded funding round was a Series A round in July 2021.
Kantum Pharma is a biotechnology company that develops therapeutic treatments and diagnostic tests for acute kidney injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kantum Pharma Comparables
Compare Kantum Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Balmes Transplantation | 78% | |
| AM-Pharma | 77% | |
| ePurines, Inc. | 77% |
For institutional investors. Book with your work email.
Kantum Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 12, 2021 | ||||
| Seed | Nov 22, 2019 | ||||
| Grant | Nov 15, 2017 |
For institutional investors. Book with your work email.
Kantum Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Series A |
| 10x Venture Partners | Series A |
| Millworks Fund | Series A |
| Broadview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2021
$4M round with participation from 10x Venture Partners and Broadview Ventures.
For institutional investors. Book with your work email.
Kantum Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kantum Pharma's valuation, stock price, and market status.
Is Kantum Pharma a public or private company?
Kantum Pharma is a private company.
What is the current stock price of Kantum Pharma?
Kantum Pharma is a private company, so its shares have no public market price. Caplight tracks Kantum Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kantum Pharma worth (valuation)?
Valuation information for Kantum Pharma is not publicly available.
Can I buy Kantum Pharma stock?
Kantum Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kantum Pharma's last funding round?
Kantum Pharma's most recent funding round was Series A on July 12, 2021.
Who are the main investors in Kantum Pharma?
Key investors in Kantum Pharma include SideCar Angels, 10x Venture Partners, Millworks Fund, Broadview Ventures.
Will Kantum Pharma IPO soon?
No public IPO plans have been announced for Kantum Pharma.
How can I track Kantum Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Kantum Pharma's shares on secondary markets.